205 research outputs found
Sustained ventricular fusion simulating a biventricular pacing
An electrocardiogram from a patient implanted with a dual-chamber DDD pacemaker showed paced QRS complexes whose morphology and frontal-plane axis were consistent with biventricular stimulation with right ventricular lead located at the apex. However, some electrocardiographic findings were suggestive, rather, of univentricular right apical pacing and sustained ventricular fusion with competing native atrioventricular conduction in the presence of patient's spontaneous QRS showing right bundle branch block plus left anterior hemiblock. Shortening atrioventricular delay with magnet application advanced right ventricle stimulation and prevented the supraventricular impulse to contribute to ventricular depolarization, thereby making clear the mechanism of right ventricular apical pacing
FDMA in Point-to-Multipoint Fibre Access Systems for Non-Residential Applications
Optical access networks are seeing growing applications for use cases beyond residential, for example in campus and as Industry 4.0 intra-factory networks, which introduce different requirements in terms of bandwidth delivery and latency. We present an uplink access system with simultaneous transmission and detection of several users by means of frequency division multiplexing (FDM). We demonstrate a multiple uplink access system with differential binary phase shift keying (DBPSK) signals and coherent detection that targets a low and deterministic latency. We achieve receiver (Rx) sensitivities of -43.5dBm, -40dBm, and -34dBm at a pre forward error correction (FEC) bit error ratio (BER) of 10 -3 at 2.5 GBaud, 5 GBaud, and 8 GBaud respectively after 20km of fibre with coherent detection. Furthermore, we show the possibility of employing time-division multiplexing (TDM) within the frequency bands. We also present real-time services showing that the system can allow latency-sensitive and best-effort applications to share the network
Circulating haematopoietic and endothelial progenitor cells are decreased in COPD
Circulating CD34+ cells are haemopoietic progenitors that may play a role in
tissue repair. No data are available on circulating progenitors in chronic
obstructive pulmonary disease (COPD). Circulating CD34+ cells were studied in 18
patients with moderate-to-severe COPD (age: mean+/-sd 68+/-8 yrs; forced
expiratory volume in one second: 48+/-12% predicted) and 12 controls, at rest and
after endurance exercise. Plasma concentrations of haematopoietic growth factors
(FMS-like tyrosine kinase 3 (Flt3) ligand, kit ligand), markers of hypoxia
(vascular endothelial growth factor (VEGF)) and stimulators of angiogenesis
(VEGF, hepatocyte growth factor (HGF)) and markers of systemic inflammation
(tumour necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-8) were measured.
Compared with the controls, the COPD patients showed a three-fold reduction in
CD34+ cell counts (3.3+/-2.5 versus 10.3+/-4.2 cells.microL-1), and a 50%
decrease in AC133+ cells. In the COPD patients, progenitor-derived haemopoietic
and endothelial cell colonies were reduced by 30-50%. However, four COPD patients
showed progenitor counts in the normal range associated with lower TNF-alpha
levels. In the entire sample, CD34+ cell counts correlated with exercise capacity
and severity of airflow obstruction. After endurance exercise, progenitor counts
were unchanged, while plasma Flt3 ligand and VEGF only increased in the COPD
patients. Plasma HGF levels were higher in the COPD patients compared with the
controls and correlated inversely with the number of progenitor-derived colonies.
In conclusion, circulating CD34+ cells and endothelial progenitors were decreased
in chronic obstructive pulmonary disease patients and could be correlated with
disease severity
NADPH oxidase and mitochondria are relevant sources of superoxide anion in the oxinflammatory response of macrophages exposed to airborne particulate matter
Exposure to ambient air particulate matter (PM) is associated with increased cardiorespiratory morbidity and mortality. In this context, alveolar macrophages exhibit proinflammatory and oxidative responses as a result of the clearance of particles, thus contributing to lung injury. However, the mechanisms linking these pathways are not completely clarified. Therefore, the oxinflammation phenomenon was studied in RAW 264.7 macrophages exposed to Residual Oil Fly Ash (ROFA), a PM surrogate rich in transition metals. While cell viability was not compromised under the experimental conditions, a proinflammatory phenotype was observed in cells incubated with ROFA 100 μg/mL, characterized by increased levels of TNF-α and NO production, together with PM uptake. This inflammatory response seems to precede alterations in redox metabolism, characterized by augmented levels of H2O2, diminished GSH/GSSG ratio, and increased SOD activity. This scenario resulted in increased oxidative damage to phospholipids. Moreover, alterations in mitochondrial respiration were observed following ROFA incubation, such as diminished coupling efficiency and spare respiratory capacity, together with augmented proton leak. These findings were accompanied by a decrease in mitochondrial membrane potential. Finally, NADPH oxidase (NOX) and mitochondria were identified as the main sources of superoxide anion ([Formula presented]) in our model. These results indicate that PM exposure induces direct activation of macrophages, leading to inflammation and increased reactive oxygen species production through NOX and mitochondria, which impairs antioxidant defense and may cause mitochondrial dysfunction
Civiltà della Campania. Anno II, n. 3 (agosto-ottobre 1975)
A. II, n.3 (agosto-ottobre 1975): Il messaggio dell’Assessore Emilio de Feo, P. 3 ; M. Parrilli, Continuità nel turismo regionale, P. 3 ; Napoli nei secoli, P. 5 ; G. Galasso, Tumulti ed elezioni del ’600, P. 6 ; N. Cilento, Nella città medioevale, P. 18 ; B. Gatta, Capri tra Napoleone e Murat, P. 24 ; R. Causa, Gioacchino Toma a Napoli, P. 30 ; A. Assante, Napoli e il suo porto, P. 34 ; G. Grimaldi, Messaggio di fede dell’Anno Santo, P. 40 ; R. Vlad, Musica all’aperto, P. 50 ; M. Stefanile, Viaggio nella storia di Amalfi, P. 52 ; D. Rea, Mappa minore, P. 60 ; M. Prisco , Incontro con la Badia, P. 68 ; P. Amos e A. Gambardella, Il villaggio di Albori, P. 74 ; R. Virtuoso, Giovanni Cuomo ritorna tra i giovani, P. 76 ; V. Panebianco, Il turismo venuto dalla storia, P. 80 ; A.P. Carbone, Le grotte di Pertosa, P. 84 ; F. de Ciuceis, Il mare di Caserta, P. 88 ; E. Tirone, Riti settennali a Guardia Sanframondi, P. 92 ; F. Calabro, Turismo e cultura a Capri, P. 98 ; F. de Ciuceis, Settembre al Borgo, P. 102 ; I. Santoro, Teggiano citta museo, P. 104 ; Notiziario, P. 108
Recommended from our members
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.
peer reviewedCancer and cardiovascular (CV) disease are the most prevalent diseases in the developed world. Evidence increasingly shows that these conditions are interlinked through common risk factors, coincident in an ageing population, and are connected biologically through some deleterious effects of anticancer treatment on CV health. Anticancer therapies can cause a wide spectrum of short- and long-term cardiotoxic effects. An explosion of novel cancer therapies has revolutionised this field and dramatically altered cancer prognosis. Nevertheless, these new therapies have introduced unexpected CV complications beyond heart failure. Common CV toxicities related to cancer therapy are defined, along with suggested strategies for prevention, detection and treatment. This ESMO consensus article proposes to define CV toxicities related to cancer or its therapies and provide guidance regarding prevention, screening, monitoring and treatment of CV toxicity. The majority of anticancer therapies are associated with some CV toxicity, ranging from asymptomatic and transient to more clinically significant and long-lasting cardiac events. It is critical however, that concerns about potential CV damage resulting from anticancer therapies should be weighed against the potential benefits of cancer therapy, including benefits in overall survival. CV disease in patients with cancer is complex and treatment needs to be individualised. The scope of cardio-oncology is wide and includes prevention, detection, monitoring and treatment of CV toxicity related to cancer therapy, and also ensuring the safe development of future novel cancer treatments that minimise the impact on CV health. It is anticipated that the management strategies discussed herein will be suitable for the majority of patients. Nonetheless, the clinical judgment of physicians remains extremely important; hence, when using these best clinical practices to inform treatment options and decisions, practitioners should also consider the individual circumstances of their patients on a case-by-case basis
Correlation analysis for energy losses, waiting times and durations of type I edge-localized modes in the Joint European Torus
Several important ELM control techniques are in large part motivated by the empirically observed inverse relationship between average ELM energy loss and ELM frequency in a plasma. However, to ensure a reliable effect on the energy released by the ELMs, it is important that this relation is verified for individual ELM events. Therefore, in this work the relation between ELM energy loss (W-ELM) and waiting time (Delta t(ELM)) is investigated for individual ELMs in a set of ITER-like wall plasmas in JET. A comparison is made with the results from a set of carbon-wall and nitrogen-seeded ITER-like wall JET plasmas. It is found that the correlation between W-ELM and Delta t(ELM) for individual ELMs varies from strongly positive to zero. Furthermore, the effect of the extended collapse phase often accompanying ELMs from unseeded JET ILW plasmas and referred to as the slow transport event (STE) is studied on the distribution of ELM durations, and on the correlation between W-ELM and Delta t(ELM). A high correlation between W-ELM and Delta t(ELM), comparable to CW plasmas is only found in nitrogen-seeded ILW plasmas. Finally, a regression analysis is performed using plasma engineering parameters as predictors for determining the region of the plasma operational space with a high correlation between W-ELM and Delta t(ELM)
Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study
PURPOSE As cancer surgery restarts after the first COVID-19 wave, health care providers urgently require data to determine where elective surgery is best performed. This study aimed to determine whether COVID-19–free surgical pathways were associated with lower postoperative pulmonary complication rates compared with hospitals with no defined pathway. PATIENTS AND METHODS This international, multicenter cohort study included patients who underwent elective surgery for 10 solid cancer types without preoperative suspicion of SARS-CoV-2. Participating hospitals included patients from local emergence of SARS-CoV-2 until April 19, 2020. At the time of surgery, hospitals were defined as having a COVID-19–free surgical pathway (complete segregation of the operating theater, critical care, and inpatient ward areas) or no defined pathway (incomplete or no segregation, areas shared with patients with COVID-19). The primary outcome was 30-day postoperative pulmonary complications (pneumonia, acute respiratory distress syndrome, unexpected ventilation). RESULTS Of 9,171 patients from 447 hospitals in 55 countries, 2,481 were operated on in COVID-19–free surgical pathways. Patients who underwent surgery within COVID-19–free surgical pathways were younger with fewer comorbidities than those in hospitals with no defined pathway but with similar proportions of major surgery. After adjustment, pulmonary complication rates were lower with COVID-19–free surgical pathways (2.2% v 4.9%; adjusted odds ratio [aOR], 0.62; 95% CI, 0.44 to 0.86). This was consistent in sensitivity analyses for low-risk patients (American Society of Anesthesiologists grade 1/2), propensity score–matched models, and patients with negative SARS-CoV-2 preoperative tests. The postoperative SARS-CoV-2 infection rate was also lower in COVID-19–free surgical pathways (2.1% v 3.6%; aOR, 0.53; 95% CI, 0.36 to 0.76). CONCLUSION Within available resources, dedicated COVID-19–free surgical pathways should be established to provide safe elective cancer surgery during current and before future SARS-CoV-2 outbreaks
- …